Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was certainly the case for me when facing my second possible recurrence of tongue cancer in just six years in the spring of 2025.
By then, I’d already undergone two oral surgeries near my home in Pennsylvania. Each one came with its own set of frustrations...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...
Understanding adenoid cystic carcinoma: Symptoms, treatment and outlook
Adenoid cystic carcinoma is a rare cancer of the secretory glands, which are glandular tissues that make and release substances such as saliva...
Astrocytoma survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
Until Groundhog Day 2018, I’d been living a healthy and normal life in Austin with my wife, Amy, and our two young children. Then one day, I woke up with a really bad headache and wound up in the emergency room with suspected meningitis. A few days later, I learned the true culprit: a type of brain tumor called astrocytoma. That diagnosis turned my whole world upside-down.
I chose UT MD Anderson for my astrocytoma treatment...
Total neoadjuvant therapy: A new era for patients with locally advanced rectal cancer
When rectal cancer advances to involve nearby lymph nodes but hasn’t spread to other areas of the body, it’s considered to be locally advanced...
7 ways to support UT MD Anderson
If you’re eager to give back to UT MD Anderson — whether because the treatment you received here extended your life or those of the people...
‘Drug hunter’ deploys AI to accelerate path to new therapies
When Tim Heffernan, Ph.D., arrived at UT MD Anderson in 2011, he saw an opportunity to fundamentally change how cancer drugs are developed...
Understanding VEXAS Syndrome: Why this often-missed condition affects men over 50
VEXAS syndrome is a clonal blood disorder that can trigger widespread inflammation throughout the body and mostly affects men over age 50....
Leukemia survivor finds companionship of rescue dog during treatment
Mark Janes’ chronic lymphocytic leukemia (CLL) diagnosis came after he’d initially visited his doctor for swollen lymph nodes in his neck....
How an electrical engineer is making a big impact on cancer research
Xiling Shen, Ph.D., was an electrical engineering professor when a landmark discovery prompted him to shift the focus of his work and dedicate...